Northwestern Medicine scientists and collaborators discovered that mutations in the TEK gene lead to primary congenital glaucoma, validating previous findings in mice and suggesting a target for future therapies.
Menu
Browsing: Uncategorized
Smartphone conversational agents like Apple’s Siri respond to questions about health crises inconsistently and incompletely, according to a recent study.
Resident Kristine Paik, MD received the American Academy of Pediatrics Resident Research Award(AAP) for her study “Incidence, independent predictors, and outcomes of unplanned, postoperative intubation in the pediatric patient” at the Society for Pediatric Anesthesia (SPA) 2016 meeting.
Northwestern researchers collaborate across fields and disciplines to use every means possible to fight HIV/AIDS.
Osefame Ewaleifoh, a second-year PhD/MPH student, studies the herpes virus in the lab of Gregory Smith, PhD. He investigates the mechanism behind differential susceptibility to herpes simplex viral encephalitis in children and the source of energy for viral transport.
Michael Ison, MD, associate professor in Medicine-Infectious Diseases and Surgery-Organ Transplantation, is co-chair of a group of scientists responsible for drafting the next edition of influenza treatment guidelines.
Her strong interest in education and traveling led alumna Evangelia Razis, MD’87, PhD, to raise awareness on breast and cervical cancer in countries such as Sudan, Honduras, Albania and Sri Lanka. Also an avid researcher, she has published more than 60 papers and has opened the first group oncology practice in Greece to pursue translational studies.
A group of scientists from Germany, Korea and the United States has shown how a member of the sirtuin gene family acts as a tumor suppressor to protect genome integrity.
Published in the Journal of Clinical Investigation, new research by Elizabeth Eklund, MD, points toward an alternative approach to treating the inherited and devastating bone marrow condition Fanconi anemia.
Patients with recurrent glioblastoma multiforme – the most aggressive form of primary brain tumor – treated with an experimental vaccine made from the patient’s own resected tumor tissue showed an improved survival rate when compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine.